RhumbLine Advisers’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,476
Closed -$165K 3134
2020
Q1
$165K Buy
1,476
+60
+4% +$6.71K ﹤0.01% 2644
2019
Q4
$347K Buy
1,416
+155
+12% +$38K ﹤0.01% 2525
2019
Q3
$434K Buy
1,261
+159
+14% +$54.7K ﹤0.01% 2399
2019
Q2
$1.01M Buy
1,102
+53
+5% +$48.8K ﹤0.01% 2065
2019
Q1
$1.67M Buy
1,049
+7
+0.7% +$11.2K ﹤0.01% 1813
2018
Q4
$1.95M Buy
1,042
+181
+21% +$339K ﹤0.01% 1659
2018
Q3
$2.03M Sell
861
-78
-8% -$184K ﹤0.01% 1652
2018
Q2
$3.23M Buy
939
+20
+2% +$68.9K 0.01% 1388
2018
Q1
$2.61M Buy
919
+19
+2% +$53.9K 0.01% 1460
2017
Q4
$2.32M Buy
900
+123
+16% +$317K ﹤0.01% 1540
2017
Q3
$2.21M Buy
777
+14
+2% +$39.7K ﹤0.01% 1550
2017
Q2
$1.8M Sell
763
-7
-0.9% -$16.5K ﹤0.01% 1645
2017
Q1
$1.94M Buy
770
+218
+39% +$549K ﹤0.01% 1572
2016
Q4
$1.25M Sell
552
-7
-1% -$15.8K ﹤0.01% 1731
2016
Q3
$1.4M Buy
559
+10
+2% +$25K ﹤0.01% 1634
2016
Q2
$1.68M Buy
549
+64
+13% +$196K 0.01% 1459
2016
Q1
$1.54M Buy
485
+21
+5% +$66.7K ﹤0.01% 1546
2015
Q4
$2.38M Buy
464
+26
+6% +$133K 0.01% 1239
2015
Q3
$1.39M Sell
438
-2
-0.5% -$6.36K ﹤0.01% 1569
2015
Q2
$1.76M Buy
440
+15
+4% +$59.9K 0.01% 1502
2015
Q1
$1.7M Buy
425
+37
+10% +$148K ﹤0.01% 1516
2014
Q4
$1.9M Sell
388
-15
-4% -$73.6K 0.01% 1390
2014
Q3
$1.64M Sell
403
-11
-3% -$44.7K ﹤0.01% 1463
2014
Q2
$1.68M Sell
414
-2
-0.5% -$8.1K ﹤0.01% 1501
2014
Q1
$1.89M Sell
416
-2
-0.5% -$9.1K 0.01% 1382
2013
Q4
$1.47M Sell
418
-36
-8% -$126K ﹤0.01% 1560
2013
Q3
$1.87M Buy
454
+21
+5% +$86.4K 0.01% 1394
2013
Q2
$1.71M Buy
+433
New +$1.71M 0.01% 1422